Robinson James A. Jr. Insider Trades

Insider Trading History

Track insider trading activity for Robinson James A. Jr.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $70.3k 2,000 shares
Last Trade
May 26, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$58.9k 2,000 shares
$29.46
$35.15
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $211k 6,000 shares
Last Trade
May 26, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$58.9k 2,000 shares
$29.46
$35.15
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Director
Holding Value $0 0 shares
Last Trade
Jan 10, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.93k 3,430 shares
$1.73
$3.95
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Director
Holding Value $13.5k 3,430 shares
Last Trade
Jan 10, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.93k 3,430 shares
$1.73
$3.95
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $70.3k 2,000 shares
Last Trade
Nov 26, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$58.8k 2,000 shares
$29.42
$35.15
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $211k 6,000 shares
Last Trade
Nov 26, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$58.8k 2,000 shares
$29.42
$35.15
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $352k 10,000 shares
Last Trade
Aug 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$195k 10,000 shares
$19.50
$35.15
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $141k 4,000 shares
Last Trade
Feb 26, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$18.7k 2,000 shares
$9.36
$35.15
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $141k 4,000 shares
Last Trade
Feb 26, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$18.7k 2,000 shares
$9.36
$35.15
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Director
Holding Value $13.5k 3,430 shares
Last Trade
Jan 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.9k 3,430 shares
$4.04
$3.95
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $352k 10,000 shares
Last Trade
Aug 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$152k 10,000 shares
$15.16
$35.15
Eledon Pharmaceuticals
Eledon Pharmaceuticals ELDN
Director
Holding Value $594k 150,437 shares
Last Trade
Oct 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$233k 150,437 shares
$1.55
$3.95
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $352k 10,000 shares
Last Trade
Sep 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$169k 10,000 shares
$16.85
$35.15
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $703k 20,000 shares
Last Trade
Jul 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$177k 20,000 shares
$8.84
$35.15
UroGen Pharma
UroGen Pharma URGN
Director
Holding Value $703k 20,000 shares
Last Trade
Jul 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$178k 20,000 shares
$8.90
$35.15
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Director
Holding Value $0 0 shares
Last Trade
Nov 30, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$9.84k 25,000 shares
$0.39
$0.39
Applied Genetic Technologies
Applied Genetic Technologies AGTC
Director
Holding Value $9.84k 25,000 shares
Last Trade
Nov 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54.3k 25,000 shares
$2.17
$0.39
Alkermes plc
Alkermes plc ALKS
President & Coo,alkermes, Inc.
Holding Value $212k 4,412 shares
Last Trade
Apr 04, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$66k 1,838 shares
$35.89
$48.07
Alkermes plc
Alkermes plc ALKS
President & Coo,alkermes, Inc.
Holding Value $901k 18,750 shares
Last Trade
Apr 04, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$224k 6,250 shares
$35.89
$48.07
Alkermes plc
Alkermes plc ALKS
President & Coo,alkermes, Inc.
Holding Value $300k 6,250 shares
Last Trade
Apr 04, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$224k 6,250 shares
$35.89
$48.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up